CACrown ArchivesThe cinema collection
Menu
Research dossier · People & Ideas

Mark A. Kay

American pediatrician and developmental genetics researcher

Correspondence, annotated notebooks and portrait silhouettes prepared for research
People and ideasInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionAug 31, 2026
Entity authorityQ59750959
Source-derived summary

Mark A. Kay is an American physician-scientist recognized for his contributions to the field of gene therapy, genome editing, and RNA biology. He has an h-index of 123, and is known for liver-directed gene therapy, demonstrating RNA interference in mammals, and advancing adeno-associated virus (AAV) vector biology.

Education

Kay earned his B.S. in Physical Sciences from Lyman Briggs College at Michigan State University in 1980, and his M.D. and Ph.D. in Developmental Genetics from Case Western Reserve University in 1987. He completed a pediatric residency, medical genetics fellowship, and postdoctoral fellowship at Baylor College of Medicine in 1993.

Career and research

Kay began his work in gene therapy in 1990. He was a founding member of the American Society of Gene and Cell Therapy (ASGCT) in 1996 and served as its Vice President, President-Elect, and President from 2003 to 2006. He played a role in establishing the society’s journal, Molecular Therapy, and advancing gene therapy research during a period of skepticism.

Kay has been a long-time editor of Human Gene Therapy. His research has led to advances in gene transfer mechanisms, vector biology, and gene regulation. He demonstrated the correction of Hemophilia B in a large animal model and filed the initial Investigational New Drug (IND) application for systemic administration of recombinant AAV in humans.

Editorial summary

This brief starts where responsible research should: with the source description of “Mark A. Kay” as american pediatrician and developmental genetics researcher. Everything that follows is an evidence route, not borrowed authority.

Editorial reviewA useful biographical orientation record, particularly for establishing names, roles and a first chronology. The current lead gives the account dated anchors—1980, 1987, 1993, 1990—that can be checked directly. The selected authority fields contribute no independent date. The account is most persuasive where Mark, American and pediatrician can be independently traced.
Editorial analysis

Why this record matters

The subject matters to the people & ideas register because the source frames it as american pediatrician and developmental genetics researcher. Its deeper value depends on whether names, dates, institutions and citations support that framing.

Evidence profile

The entry’s evidential value lies in the named roles, institutions and publications that can be tested against primary documentation. The source revision retrieved here is dated Aug 31, 2026. The linked authority identifier is Q59750959. VIAF identifies the subject as 60698774. The Library of Congress control number is n90609456. None of the 3 selected statements returned an explicit reference. The first chronological checks are 1980, 1987, 1993 and 1990.

Critical limits

A concise life account rarely captures disputed attribution, private networks or the changing language used to describe a career. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Read biographical claims against dates, named institutions and the cited references. Distinguish a subject’s later reputation from evidence produced during their lifetime.

Best used for
  • Establishing names and roles
  • Building a first chronology
  • Locating cited institutions
Verify next

Personal papers, civil or court records, institutional files and the scholarship cited by the source.

Three-step research path

  1. Establish the record: confirm the title “Mark A. Kay”, its source revision and the description used here.
  2. Expand the search: follow Mark A. Kay primary sources, Mark A. Kay archive and Mark research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Mark A. Kay”?
  2. Which primary records establish identity, chronology and institutional ties?
  3. How has the subject’s reputation changed across later accounts?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Mark A. Kay” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.